ENTITY

Zhejiang Medicine Co Ltd A (600216 CH)

12
Analysis
Health CareChina
Zhejiang Medicine Co., Ltd. manufactures and markets chemical medicines and preparations including antibiotics, vitamins, and other pharmaceuticals. Through its subsidiaries, the Company also operates in food manufacturing.
more
Refresh
bullishRemegen
12 Oct 2021 09:04

Remegen Co Ltd (9995.HK) - Insights About the First Round Enquiry by Shanghai Stock Exchange

This article mainly analyzed RemeGen in terms of its reply to Shanghai Stock Exchange’s first round enquiry,  the core products, the pipeline, the...

Logo
213 Views
Share
bullishRemegen
23 Jun 2021 08:51

RemeGen Co Ltd (9995.HK) - Here Are the Strength and Concerns After Commercialization

This article mainly analyzed RemeGen in terms of its commercialization of the two core products RC48 and RC18, and the concerns on its pipeline.

Logo
188 Views
Share
bearishLepu Biopharma
13 May 2021 09:08

Pre-IPO Lepu Biopharma - There Are Still Many Uncertainties

This article analyzed Lepu Biopharma in terms of its core product candidates in the pipeline, the challenges, concerns and future outlook for this...

Logo
291 Views
Share
bullishRemegen
15 Mar 2021 09:12

Remegen Co Ltd (9995.HK) - Commercialized RC18 + IPO On SSE STAR Market = New Chapter & Challenges

The article analyzed RemeGen's first commericalized product RC18, the challenges in R&D failure, fierce competition, commercialization and...

Logo
234 Views
Share
05 Jan 2021 09:51

Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape

This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...

Logo
322 Views
Share
x